Skip Navigation
Celldex Therapeutics logo Celldex logo
Main Nav
  • Our Company
    • About Us
    • Leadership
      • Management
      • Board of Directors
      • Scientific Advisory Board
    • Contact Us
  • Pipeline
    • Pipeline Overview
    • Therapeutic Areas
      • Inflammation
      • Oncology
    • Clinical Trials
      • Compassionate Use
  • Science
    • Antibody-Based Therapeutics
      • Bispecific Platform
    • Publications
  • Investors & Media
    • Investor & Media Home
    • Press Releases
    • Events & Presentations
    • Analyst Coverage
    • Financials & Filings
      • SEC Filings
      • Quarterly Results
      • Annual Reports & Proxies
    • Corporate Governance
      • Documents & Charters
      • Management
      • Board of Directors
      • Scientific Advisory Board
      • Committee Composition
    • Investor Resources
      • Contact Us
      • Email Alerts
  • Careers
  • Contact Us
  • Search Toggle
background image of cells and shapes
Investors
& Media

SEC Filing Details

« Back

Document Details

Form
10-Q
Filing Date
Nov 7, 2018
Document Date
Sep 30, 2018
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
Celldex Therapeutics
Issuer
CELLDEX THERAPEUTICS, INC.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.INS - XBRL INSTANCE DOCUMENT
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
EX-101.LAB - XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
Main Nav
  • Investor & Media Home
  • Press Releases
  • Events & Presentations
  • Analyst Coverage
  • Financials & Filings
    • SEC Filings
    • Quarterly Results
    • Annual Reports & Proxies
  • Corporate Governance
    • Documents & Charters
    • Management
    • Board of Directors
    • Scientific Advisory Board
    • Committee Composition
  • Investor Resources
    • Contact Us
    • Email Alerts

Investor & Media Inquiries

Sarah Cavanaugh
Senior Vice President
Corporate Affairs and Administration
 
IR@celldex.com
Celldex Therapeutics logo
info@celldex.com
53 Frontage Road
Suite 220
Hampton NJ 08827
(908) 454-7120
300 George Street
Suite 530
New Haven, CT 06511
(203) 483-3500
151 Martine Street
Fall River, MA 02723


(508) 742-4300
160 Gould Street
Suite 202
Needham, MA 02494

(781) 433-0771

©2023 Celldex Therapeutics. All Rights Reserved.

Footer Links
  • Privacy Policy
  • Research Conflicts of Interest Policy
  • Terms of Use
  • Site Map